Publikationen, an denen er mitarbeitet Oreste Gualillo (8)

2022

  1. The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile

    Frontiers in Pharmacology, Vol. 13

2019

  1. Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats

    Biochemical Pharmacology, Vol. 170

2015

  1. IL-36α: A novel cytokine involved in the catabolic and inflammatory response in chondrocytes

    Scientific Reports, Vol. 5

2013

  1. Nesfatin-1 in human and murine cardiomyocytes: Synthesis, secretion, and mobilization of GLUT-4

    Endocrinology, Vol. 154, Núm. 12, pp. 4757-4767

2006

  1. Ghrelin In The Local Regulation Of Endocrine Glands

    Handbook of Biologically Active Peptides (Elsevier Inc.), pp. 869-875

2005

  1. The endogenous growth hormone secretagogue (Ghrelin) is synthesized and secreted by chondrocytes

    Endocrinology, Vol. 146, Núm. 3, pp. 1285-1292

2003

  1. Resistin is expressed in different rat tissues and is regulated in a tissue- and gender-specific manner

    FEBS Letters, Vol. 548, Núm. 1-3, pp. 21-27

2001

  1. Ghrelin, a novel placental-derived hormone

    Endocrinology, Vol. 142, Núm. 2, pp. 788-794